Alice B. Gottlieb, MD, PhD
 Clinical Professor of Dermatology, Department of Dermatology
 Division of Rheumatology
 Icahn School of Medicine at Mount Sinai
 Medical Director, Department of Dermatology
 Mount Sinai at Union Square
 New York, NY

Alice B. Gottlieb, MD, PhD is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. Through a study she had published in Lancet in 2001, Dr. Gottlieb was the first to show the efficacy of TNF blockers as monotherapy for moderate to severe psoriasis. Her research led to multiple TNF blockers being FDA-approved for psoriasis which revolutionized the care of psoriasis and psoriatic arthritis patients. In addition, Dr. Gottlieb was one of the first scientists to demonstrate that psoriasis is a T cell mediated disease. She showed that treatment with a T cell-specific immunotoxin cleared psoriasis clinically and histologically. With her published studies and public presentations she has been able to convince pharmaceutical companies to use psoriasis as their proof-of-concept disease when testing new immunomodulators that may decrease T cell and dendritic cell cytokine production. So far, her research has affected drug development in psoriasis, psoriatic arthritis, rheumatoid arthritis, inflammatory bowel disease and transplantation.

Abby S. Van Voorhees, MD 
 Professor and Chair, Department of Dermatology 
 Eastern Virginia Medical School
 Norfolk, VA

Abby S. Van Voorhees, MD is a professor, chair and residency director of the department of dermatology at the Eastern Virginia Medical School. She obtained her B.A. from Brown University in 1979 in biology and received her M.D. from Yale University in 1983. She completed her dermatology residency at the Yale-New Haven Hospital in 1988, serving as the chief resident from July 1987 to 1988. In addition to her current position, Dr. Van Voorhees has also worked in the University of Pennsylvania Department of Dermatology and the University of Connecticut Department of Medicine. She has been active in clinical research issues in dermatology, particularly those related to the treatment of psoriasis. Dr. Van Voorhees is the chair of the Medical Board of the National Psoriasis Foundation and is also on the Board of Directors of the American Academy of Dermatology. She previously was the Medical Editor of Dermatology World. Additionally, she has served on several of the American Academy of Dermatology’s committees and task forces, including serving as the chairman for the Guidelines of Care task force. She is the author of over 90 publications.
 

DISCLOSURE INFORMATION
The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

Program Faculty 
The faculty, authors and content developers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Alice B. Gottlieb, MD, PhD: Honoraria for Advisory Board Member and Consultant: Anaptyps Bio, Avotres Therapeutics, Beiersdorf, Boehringer Ingelheim, Bristol-Myers Suibb Co., Eli Lilly, Janssen, LEO Pharma, Novartis, Sun Pharmaceutical Industries, Inc., UCB; Stock Options: Xbiotech; Grant/Research Support: Boehringer Ingelheim, Janssen, Novartis, Sun Pharmaceutical Industries, Inc., UCB, Xbiotech

Abby S. Van Voorhees, MD: Grant/Research Support: AbbVie, Celgene, Lilly; Honoraria: Amgen, Boehringer Ingelheim, Bristol Myers Squibb, UCB 

Planners and Managers
The planners and mangers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:  

Terry Ann Glauser, MD, MPH: Nothing to disclose

Content Reviewers 
The content reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Katie Propst, PhD: Nothing to disclose

FDA DISCLOSURE 
The contents of some CME activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses